A machine learning approach to screen for preclinical Alzheimer's disease - Inria - Institut national de recherche en sciences et technologies du numérique Access content directly
Journal Articles Neurobiology of Aging Year : 2021

A machine learning approach to screen for preclinical Alzheimer's disease

Lionel Naccache

Abstract

Combining multimodal biomarkers could help in the early diagnosis of Alzheimer's disease (AD). We included 304 cognitively normal individuals from the INSIGHT-preAD cohort. Amyloid and neurodegeneration were assessed on 18F-florbetapir and 18F-fluorodeoxyglucose PET, respectively. We used a nested cross-validation approach with non-invasive features (electroencephalography [EEG], APOE4 genotype, demographic, neuropsychological and MRI data) to predict: 1/ amyloid status; 2/ neurodegeneration status; 3/ decline to prodromal AD at 5-year follow-up. Importantly, EEG was most strongly predictive of neurodegeneration, even when reducing the number of channels from 224 down to 4, as 4-channel EEG best predicted neurodegeneration (negative predictive value [NPV] = 82%, positive predictive value [PPV] = 38%, 77% specificity, 45% sensitivity). The combination of demographic, neuropsychological data, APOE4 and hippocampal volumetry most strongly predicted amyloid (80% NPV, 41% PPV, 70% specificity, 58% sensitivity) and most strongly predicted decline to prodromal AD at 5 years (97% NPV, 14% PPV, 83% specificity, 50% sensitivity). Thus, machine learning can help to screen patients at high risk of preclinical AD using non-invasive and affordable biomarkers.
Fichier principal
Vignette du fichier
Gaubert et al. - 2021 - A machine learning approach to screen for preclini.pdf (630.17 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-03261206 , version 1 (15-06-2021)

Identifiers

Cite

Sinead Gaubert, Marion Houot, Federico Raimondo, Manon Ansart, Marie-Constance Corsi, et al.. A machine learning approach to screen for preclinical Alzheimer's disease. Neurobiology of Aging, 2021, 105, pp.205-216. ⟨10.1016/j.neurobiolaging.2021.04.024⟩. ⟨hal-03261206⟩
222 View
205 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More